Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.80 |
| ▸ | MAPT | P10636 | 2/20 | 0.70 |
| ▸ | MEN1 | O00255 | 2/20 | 0.70 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.70 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.70 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.70 |
| ▸ | SQLE | Q14534 | 7/20 | 0.67 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.61 |
| ▸ | FNTA | P49354 | 1/20 | 0.55 |
| ▸ | FNTB | P49356 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3092587 | 1.00 | KMT2A (0.80) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| SCHEMBL28731350 | 1.00 | KMT2A (0.80) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| SCHEMBL12713311 | 1.00 | KMT2A (0.80) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| SCHEMBL3090338 | 1.00 | KMT2A (0.80) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| SCHEMBL6716175 | 1.00 | KMT2A (0.80) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| SCHEMBL17047981 | 1.00 | KMT2A (0.80) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| SCHEMBL10510234 | 1.00 | KMT2A (0.80) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| SCHEMBL3090339 | 1.00 | KMT2A (0.80) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| SCHEMBL27916633 | 0.97 | KMT2A (0.76) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| SCHEMBL2987781 | 0.95 | KMT2A (0.70) | KMT2AMAPTMEN1CYP3A4ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170283354-A1 | PROCESS FOR THE PREPARATION OF VITAMIN K2 | KAPPA BIOSCIENCE AS (NO) | 2017-10-05 | — | — | US | disclosed |
| EP-3018116-A1 | VITAMIN K2 INTERMEDIATES | Kappa Bioscience As (NO) | 2016-05-11 | — | — | EP | disclosed |
| US-20150210620-A1 | PROCESS FOR THE PREPARATION OF VITAMIN K2 | KAPPA BIOSCIENCE AS (NO) | 2015-07-30 | — | — | US | disclosed |
| US-9012693-B2 | Process for the preparation of vitamin K2 | KAPPA BIOSCIENCE AS (NO) | 2015-04-21 | — | — | US | disclosed |
| US-20110207967-A1 | PROCESS FOR THE PREPARATION OF VITAMIN K2 | KAPPA BIOSCIENCE AS (NO) | 2011-08-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170283354-A1 | PROCESS FOR THE PREPARATION OF VITAMIN K2 | PROC, VKORC1, VKORC1L1 | KMT2A 206/4885MAPT 4724/4885MEN1 44/4885 |
| US-20110207967-A1 | PROCESS FOR THE PREPARATION OF VITAMIN K2 | PROC, VKORC1, VKORC1L1 | KMT2A 225/4885MAPT 4700/4885MEN1 44/4885 |
| US-20150210620-A1 | PROCESS FOR THE PREPARATION OF VITAMIN K2 | PROC, VKORC1, VKORC1L1 | KMT2A 206/4885MAPT 4724/4885MEN1 44/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.